Mae'r cynnwys hwn ar gael yn Saesneg yn unig.
Cardiff University has formed a partnership with Takeda Pharmaceutical Company Limited (Takeda) for a drug discovery collaboration to identify new approaches for treating schizophrenia and other psychiatric disorders.
The collaboration will combine the University's large scale genomic data and world-class expertise in psychiatric genetics, genomics, clinical and basic neuroscience with Takeda’s extensive drug discovery and clinical development capabilities.
The collaboration will allow Takeda access to world-leading biological psychiatry research and the related infrastructure across the University, including the
For more information regarding the Takeda partnership, please contact: